{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:15:38Z","timestamp":1761714938191,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.pcd.2014.01.010","type":"journal-article","created":{"date-parts":[[2014,2,9]],"date-time":"2014-02-09T08:00:17Z","timestamp":1391932817000},"page":"256-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center"],"prefix":"10.1016","volume":"8","author":[{"given":"Soner","family":"Cander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguzhan Sitki","family":"Dizdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozen","family":"Oz Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"Guclu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguz Kaan","family":"Unal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercan","family":"Tuncel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdinc","family":"Erturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sazi","family":"Imamoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2014.01.010_bib0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM198805123181903","article-title":"Abnormal patterns of insulin secretion in non-insulin dependent diabetes mellitus","volume":"318","author":"Polonsky","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcd.2014.01.010_bib0010","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2014.01.010_bib0015","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diabetes.53.6.1614","article-title":"Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes","volume":"53","author":"Heise","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2014.01.010_bib0020","article-title":"Basal insulin analogues in the management of diabetes mellitus: what progress have we made?","author":"Owens","year":"2013","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.pcd.2014.01.010_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3121\/cmr.2008.793","article-title":"Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence","volume":"6","author":"Hartman","year":"2008","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.pcd.2014.01.010_bib0030","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1023\/B:PHAM.0000036926.54824.37","article-title":"The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin","volume":"21","author":"Havelund","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.pcd.2014.01.010_bib0035","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2337\/diacare.28.5.1107","article-title":"A doubleblind, randomized, dose\u2013response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir","volume":"28","author":"Plank","year":"2005","journal-title":"Diabetes Care"},{"year":"2009","series-title":"Levemir\u00ae (Insulin Detemir [rDNA Origin] Injection) [Prescribing Information]","key":"10.1016\/j.pcd.2014.01.010_bib0040"},{"issue":"3","key":"10.1016\/j.pcd.2014.01.010_bib0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1463-1326.2006.00685.x","article-title":"Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time\u2013action profiles but less variability than insulin glargine in type 2 diabetes","volume":"9","author":"Klein","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2014.01.010_bib0050","first-page":"27","article-title":"Detemir as a once-daily basal insulin in type 2 diabetes","volume":"3","author":"Nelson","year":"2011","journal-title":"Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.pcd.2014.01.010_bib0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/dc08-0332","article-title":"Comparison of once-versus twice-daily administration of insulin detemir: used with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes assessment of detemir administration in a progressive treat-to-target trial (ADAPT)","volume":"32","author":"Le Floch","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.01.010_bib0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/dmrr.762","article-title":"Refining basal insulin therapy: what have we learned in the age of analogs?","volume":"23","author":"DeVries","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.pcd.2014.01.010_bib0065","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00125-007-0911-x","article-title":"A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes","volume":"51","author":"Rosenstock","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2014.01.010_bib0070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/dmrr.989","article-title":"Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes","volume":"25","author":"Raskin","year":"2009","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.pcd.2014.01.010_bib0075","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1463-1326.2006.00677.x","article-title":"PREDICTIVE \u2013 a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort","volume":"9","author":"Luddeke","year":"2007","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.pcd.2014.01.010_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1463-1326.2007.00816.x","volume":"10","author":"Dornhorst","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2014.01.010_bib0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12325-009-0033-6","article-title":"Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE","volume":"26","author":"Fontaine","year":"2009","journal-title":"Adv. Ther."},{"key":"10.1016\/j.pcd.2014.01.010_bib0090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1463-1326.2006.00674.x","volume":"9","author":"Meneghini","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2014.01.010_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1900\/RDS.2007.4.89","article-title":"3-Month results from Denmark within the globally prospective and observational study to evaluate insulin detemir treatment in type 1 and type 2 diabetes: the PREDICTIVE study","volume":"4","author":"Hermansen","year":"2007","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.pcd.2014.01.010_bib0100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1742-1241.2008.01715.x","article-title":"Insulin detemir improves glycaemic control without weight gain in insulin\u2013naive patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study","volume":"62","author":"Dornhorst","year":"2008","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.pcd.2014.01.010_bib0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1055\/s-2000-5887","article-title":"Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans","volume":"108","author":"Brunner","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.pcd.2014.01.010_bib0110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2337\/diacare.10.6.697","article-title":"Metabolic control in noninsulin-dependent diabetes mellitus: factors associated with patient outcomes","volume":"10","author":"O\u2019Connor","year":"1987","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.pcd.2014.01.010_bib0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diacare.22.3.463","article-title":"A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group","volume":"22","author":"Wolffenbuttel","year":"1999","journal-title":"Diabetes Care"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991814000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991814000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:54:59Z","timestamp":1761695699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991814000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1751991814000114"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2014.01.010","relation":{},"ISSN":["1751-9918"],"issn-type":[{"type":"print","value":"1751-9918"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2014.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}